co-founder of Biofficient, is a seasoned entrepreneur with over 20 years of experience initiating and leading technology companies in the design and application of innovative market-demanded solutions as well as creating new markets more....His extensive experience spans the mobile, gaming, healthcare, software, semiconductor and electronics industries. Mr. Siarkowski is a Limited Partner at Kodiak Venture Partners, angel investor and serves on the Board of Advisors for several technology companies. Mr. Siarkowski holds a BSEE from Northeastern University and an MSEE from the University of Southern California. He also holds several patents that cover both software and hardware industries.
Chairman (Ret.) & Co-Founder, American Renal Associates, Inc. American Renal Associates, Inc. (ARA) is one of the largest dialysis providers in the US more....and offers an alternative to traditional large dialysis chain ownership. Mr. Ford co-founded ARA in August 1999 with two colleagues from Fresenius Medical Care, the world's largest dialysis company. Today ARA owns and operates over 120 outpatient dialysis clinics, in 20 states and the District of Columbia, treating over 8000 patients and employing over 1600. Mr. Ford is also the former President of Fresenius Medical Care's International Services Division. He grew the Fresenius international division from a small presence in Spain and Portugal, to a worldwide organization providing care for 10,000 chronic dialysis patients in 14 countries. Earlier, he was responsible for all U.S. operations and held the position of Senior Vice President of Operations for the U.S. Dialysis Services Division. He has worked in the dialysis services industry since 1971, and during his 40+ year career he has contributed to the build out of the U.S. dialysis market from its infancy in the 1970's to an $8 billion healthcare business today. Mr. Ford received his BS degree in Business Administration from Northeastern University (Boston, MA)
co-founder of Biofficient, is an accomplished, business professional with extensive life sciences business, technology and service experience. more....Her proven successes in developing markets and targeting industry segments generate top line growth through client focused programs and competitive product advantages. Prior to founding Biofficient, Ms. Wills was the Vice President, Corporate Marketing for PAREXEL International, a global biopharmaceutical services company where she directed multi-faceted national and international marketing programs that increasingly contributed to sales growth for 3 consecutive years. She has led the strategic planning process and marketing initiatives as core member of management team for two life sciences technology-based leaders, Phase Forward and Outcome Sciences. Ms. Wills holds a BSEE from Western New England University and a MBA, Marketing Concentration, from Keller Graduate School.
Mr. Ciampolini is a healthcare entrepreneur and co-founder of Healthcare Capital Partners, a London based private equity and corporate finance advisory boutique specialized in life sciences and healthcare ventures. more....He is also an Adjunct Professor of Imperial College Business School in London. Mr. Ciampolini started his professional career with his family's group of companies, which included private clinics and diagnostic equipment manufacturing in Italy, France and the United States. He joined Arthur Andersen in London in 1996, where he was a member of its healthcare corporate finance team. In 1999, he founded NephroNet, a chain of independent dialysis centres, which was acquired by Baxter Inc. in 2001. From 2001 to 2003 Stefano was a Managing Director of Baxter Renal Therapy Services and since 2007 he has served has CEO of the Renal Services Group, a dialysis services company based in London which he founded. As part of his investment activities Mr. Ciampolini is a founder, board member and investor in several healthcare ventures and private equity funds focusing on healthcare investments in Europe and the US. He is a board member of General Genetics Corporation, a US genetic company, a founder and board member of Pure Life Renal, a US dialysis services company, a founder and board member of Biofficient, a biotech e-platform, and a partner at Boss Group, a global investment firm. Mr. Ciampolini earned an MBA from Imperial College Business School in London in 1994 and holds a degree in economics from Kingston University in Surrey.